Pleiotropic roles of bile acids in metabolism.

[1]  Fei Li,et al.  FXR signaling in the enterohepatic system , 2013, Molecular and Cellular Endocrinology.

[2]  T. Coffman,et al.  A trip to inner space: insights into salt balance from cosmonauts. , 2013, Cell metabolism.

[3]  Brian J. Bennett,et al.  Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. , 2013, Cell metabolism.

[4]  F. Bäckhed,et al.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.

[5]  F. Cattaruzza,et al.  The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. , 2013, Gastroenterology.

[6]  B. Angelin,et al.  Circulating fibroblast growth factors as metabolic regulators--a critical appraisal. , 2012, Cell metabolism.

[7]  Y. Maehara,et al.  Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. , 2012, American journal of human genetics.

[8]  D. Häussinger,et al.  Perspective: TGR5 (Gpbar-1) in liver physiology and disease. , 2012, Clinics and research in hepatology and gastroenterology.

[9]  Barbara Gross,et al.  Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease , 2012, Journal of Lipid Research.

[10]  J. Chiang,et al.  Mechanism of tissue‐specific farnesoid X receptor in suppressing the expression of genes in bile‐acid synthesis in mice , 2012, Hepatology.

[11]  F. Schaap.  Role of fibroblast growth factor 19 in the control of glucose homeostasis , 2012, Current opinion in clinical nutrition and metabolic care.

[12]  F. Gonzalez,et al.  Pregnane X receptor as a target for treatment of inflammatory bowel disorders. , 2012, Trends in pharmacological sciences.

[13]  J. Auwerx,et al.  TGR5 potentiates GLP-1 secretion in response to anionic exchange resins , 2012, Scientific Reports.

[14]  C. Klaassen,et al.  Characterization of Bile Acid homeostasis in Germ‐free Mice , 2012 .

[15]  J. Ware,et al.  Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Yunwei Wang,et al.  Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice , 2012, Nature.

[17]  Yusuke Nakamura,et al.  A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population , 2022 .

[18]  P. Tontonoz,et al.  Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR , 2012, Nature Reviews Molecular Cell Biology.

[19]  S. Kliewer,et al.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. , 2012, Genes & development.

[20]  G. Dockray.  Cholecystokinin , 2012, Current opinion in endocrinology, diabetes, and obesity.

[21]  K. Linton,et al.  Canalicular ABC transporters and liver disease , 2012, The Journal of pathology.

[22]  S. Spiegel,et al.  Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes , 2012, Hepatology.

[23]  H. Jaeschke,et al.  Effect of bile duct ligation on bile acid composition in mouse serum and liver , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[24]  J. Iser,et al.  Chenodeoxycholic Acid: A Review of its Pharmacological Properties and Therapeutic Use , 1981, Drugs.

[25]  Stacey A. Jones.  Physiology of FGF15/19. , 2012, Advances in experimental medicine and biology.

[26]  J. Auwerx,et al.  TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. , 2011, Cell metabolism.

[27]  B. Angelin,et al.  Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19 , 2011, Journal of internal medicine.

[28]  B. M. Forman,et al.  The G‐Protein‐coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light‐chain enhancer of activated B cells (NF‐κB) in mice , 2011, Hepatology.

[29]  Li Wang,et al.  Role of nuclear receptor SHP in metabolism and cancer. , 2011, Biochimica et biophysica acta.

[30]  R. Straka,et al.  Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting , 2011, PloS one.

[31]  S. Kliewer,et al.  FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. , 2011, Cell metabolism.

[32]  D. Häussinger,et al.  TGR5 in the Biliary Tree , 2011, Digestive Diseases.

[33]  J. Auwerx,et al.  The Bile Acid Membrane Receptor TGR5: A Valuable Metabolic Target , 2011, Digestive Diseases.

[34]  S. Kliewer,et al.  The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. , 2011, Molecular endocrinology.

[35]  S. Kliewer,et al.  FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis , 2011, Science.

[36]  L. Peltonen,et al.  Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis , 2011, Nature Genetics.

[37]  C. Klaassen,et al.  Diurnal Variations of Mouse Plasma and Hepatic Bile Acid Concentrations as well as Expression of Biosynthetic Enzymes and Transporters , 2011, PloS one.

[38]  K. Zilles,et al.  The bile acid receptor TGR5 (Gpbar‐1) acts as a neurosteroid receptor in brain , 2010, Glia.

[39]  E. Want,et al.  Systemic gut microbial modulation of bile acid metabolism in host tissue compartments , 2010, Proceedings of the National Academy of Sciences.

[40]  M. Nelson,et al.  Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels , 2010, The Journal of physiology.

[41]  P. Dawson,et al.  Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism. , 2010, Biochimica et biophysica acta.

[42]  I. Björkhem,et al.  Genetic connections between neurological disorders and cholesterol metabolism , 2010, Journal of Lipid Research.

[43]  Yanqiao Zhang,et al.  Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity. , 2010, Molecular endocrinology.

[44]  Fabio Macciardi,et al.  Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis , 2010, Nature Genetics.

[45]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[46]  P. Griffin,et al.  Faculty of 1000 evaluation for TGR5-mediated bile acid sensing controls glucose homeostasis. , 2010 .

[47]  P. Sham,et al.  Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. , 2010, Human molecular genetics.

[48]  Xiaohui Xie,et al.  Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1 , 2010, Nucleic acids research.

[49]  Ann M. Thomas,et al.  Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine , 2010, Hepatology.

[50]  S. Kliewer,et al.  Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D* , 2010, The Journal of Biological Chemistry.

[51]  V. Fonseca,et al.  Bile Acid Sequestrants for Lipid and Glucose Control , 2010, Current diabetes reports.

[52]  P. Dawson.  Bile Secretion and the Enterohepatic Circulation , 2010 .

[53]  L. Adorini,et al.  The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. , 2009, American journal of physiology. Renal physiology.

[54]  J. Chiang,et al.  Bile acids: regulation of synthesis , 2009, Journal of Lipid Research.

[55]  J. Auwerx,et al.  TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.

[56]  D. Häussinger,et al.  The membrane‐bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders , 2009, Hepatology.

[57]  D. Gouma,et al.  High expression of the bile salt‐homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis , 2009, Hepatology.

[58]  B. Staels,et al.  Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.

[59]  B. Bouscarel,et al.  Bile acids and signal transduction: role in glucose homeostasis. , 2008, Cellular signalling.

[60]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[61]  D. Häussinger,et al.  Expression and function of the bile acid receptor TGR5 in Kupffer cells. , 2008, Biochemical and biophysical research communications.

[62]  P. Dawson,et al.  The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis , 2008, Proceedings of the National Academy of Sciences.

[63]  J. Auwerx,et al.  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. , 2008, Journal of medicinal chemistry.

[64]  S. Asano,et al.  Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray. , 2008, Acta histochemica.

[65]  Liming Pei,et al.  Nuclear receptors: Decoding metabolic disease , 2008, FEBS letters.

[66]  P. Edwards,et al.  FXR signaling in metabolic disease , 2008, FEBS letters.

[67]  J. Auwerx,et al.  Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. , 2007, Biochemical and biophysical research communications.

[68]  K. Setchell,et al.  Inborn Errors of Bile Acid Metabolism , 2007, Seminars in liver disease.

[69]  Michael Krawczak,et al.  A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease , 2007, Nature Genetics.

[70]  T. Lundåsen,et al.  Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man , 2006, Journal of internal medicine.

[71]  S. Kliewer,et al.  Identification of a hormonal basis for gallbladder filling , 2006, Nature Medicine.

[72]  H. Miyoshi,et al.  Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. , 2006, The Journal of endocrinology.

[73]  H. Davis,et al.  Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. , 2006, The Biochemical journal.

[74]  M. Trauner,et al.  Molecular mechanisms of cholestasis , 2006, Wiener Medizinische Wochenschrift.

[75]  Folkert Kuipers,et al.  The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice* , 2006, Journal of Biological Chemistry.

[76]  Ke Ma,et al.  Farnesoid X receptor is essential for normal glucose homeostasis. , 2006, The Journal of clinical investigation.

[77]  D. Mangelsdorf,et al.  LXRS and FXR: the yin and yang of cholesterol and fat metabolism. , 2006, Annual review of physiology.

[78]  Dae-Joong Kang,et al.  Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.

[79]  J. Auwerx,et al.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.

[80]  Timothy M Willson,et al.  Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[81]  S. Nelson,et al.  FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine Published, JLR Papers in Press, October 26, 2005. , 2006, Journal of Lipid Research.

[82]  S. Nelson,et al.  FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. , 2006, Journal of lipid research.

[83]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[84]  Y. Nabeshima,et al.  Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. , 2005, The Journal of clinical investigation.

[85]  G. Tsujimoto,et al.  Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. , 2005, Biochemical and biophysical research communications.

[86]  J. Costerton,et al.  Defense system in the biliary tract against bacterial infection , 1992, Digestive Diseases and Sciences.

[87]  Sander M Houten,et al.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. , 2004, The Journal of clinical investigation.

[88]  C. Fiorentini,et al.  Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes. , 2004, Molecular biology of the cell.

[89]  C. Fiorentini,et al.  Rac GTPase Instructs Nuclear Factor-κB Activation by Conveying the SCF Complex and IkBα to the Ruffling Membranes , 2003 .

[90]  Bryan Goodwin,et al.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.

[91]  Jonathan C. Cohen,et al.  ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion* , 2003, Journal of Biological Chemistry.

[92]  D. Russell.  The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[93]  P. Dawson,et al.  Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice* , 2003, Journal of Biological Chemistry.

[94]  S. Kliewer,et al.  Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.

[95]  Masataka Harada,et al.  A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.

[96]  Takao Nakamura,et al.  Identification of membrane-type receptor for bile acids (M-BAR). , 2002, Biochemical and biophysical research communications.

[97]  M. Remberger,et al.  Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. , 2002, Blood.

[98]  D. Russell,et al.  Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. , 2002, Developmental cell.

[99]  M. Karin,et al.  Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.

[100]  M. Haussler,et al.  Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.

[101]  D. Russell,et al.  Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. , 2001, Journal of lipid research.

[102]  M. Makishima,et al.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.

[103]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[105]  C. Deng,et al.  Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.

[106]  N. Javitt,et al.  27-hydroxycholesterol: production rates in normal human subjects. , 1999, Journal of lipid research.

[107]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[108]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[109]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[110]  P. Dawson,et al.  Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). , 1997, The Journal of clinical investigation.

[111]  J. Zerwekh,et al.  Disruption of Cholesterol 7α-Hydroxylase Gene in Mice , 1996, The Journal of Biological Chemistry.

[112]  D. Russell,et al.  Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. , 1996, The Journal of biological chemistry.

[113]  Jasmine Chen,et al.  Identification of a nuclear receptor that is activated by farnesol metabolites , 1995, Cell.

[114]  D. Moore,et al.  Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. , 1995, Molecular endocrinology.

[115]  S. Hayakawa.  [Enterohepatic circulation of bile acids]. , 1984, Nihon rinsho. Japanese journal of clinical medicine.

[116]  K. Einarsson,et al.  Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. , 1982, The Journal of clinical investigation.

[117]  N. Javitt,et al.  Bile acid synthesis in man: metabolism of 7 -hydroxycholesterol- 14 C and 26-hydroxycholesterol- 3 H. , 1972, The Journal of clinical investigation.